Ensign Group Beats EPS, Misses Revenue but Raises FY2026 Guidance, Stock Edges Higher

Earnings Summary

Ensign Group reported GAAP diluted earnings per share of $1.67, a 21.9% YoY increase and a $0.06 beat over analysts’ expectations. Adjusted (non‑GAAP) EPS came in at $1.85, also above the $1.79 consensus. Net income rose 24.2% YoY to $99.7 million. However, total revenue of $1.0 billion missed the consensus of $1.40 billion, a shortfall of roughly $400 million (the filing lists a $1.4 billion estimate, the live data shows a $1 billion actual). Skilled services revenue grew 18.4% YoY to $1.33 billion, and occupancy hit record highs of 84.3% (same facilities) and 85.1% (transitioning facilities).

Guidance & Outlook

During the release, Ensign announced an upward revision to its FY2026 outlook:

- EPS guidance: $7.48‑$7.62 per diluted share (vs. consensus $7.37).

- Revenue guidance: $5.81‑$5.86 billion (vs. consensus $5.80 billion).

The company cited strong Medicare and managed‑care mix, higher acuity admissions, and continued acquisition momentum as the drivers behind the upgrade. The guidance lift signals confidence that the occupancy and skilled‑mix trends will sustain earnings growth throughout the year.

Conference Call Highlights

Management hosted a conference call on May 1, 2026 at 10:00 am PT. CEO Barry Port highlighted:

- Record occupancy and a 9.6% increase in combined skilled‑mix revenue YoY.

- Medicare revenue growth of ~9.8% across same‑store and transitioning facilities.

- The company’s diversified payer and geographic mix insulating it from localized reimbursement pressure.

- Ongoing acquisition pipeline that will add roughly 30‑40 facilities in the next 12 months, expanding the skilled‑services platform.

Port emphasized that the “patient‑focused culture” is translating into higher‑quality outcomes, which in turn drives referral strength and higher‑acuity case capture.

Market Reaction

The earnings beat on EPS and the guidance upgrade sparked a modest after‑hours rally, with ENSG shares climbing 0.43% to $187.50 from the prior close of $186.69. Trading volume was modestly elevated, reflecting investors’ focus on the upgraded outlook rather than the revenue miss.

Analyst Commentary

- MarketBeat noted the guidance lift as “a clear sign of confidence in continued demand for skilled‑services and Medicare mix improvements,” which helped offset the revenue shortfall in the short term.

- Business Insider highlighted that the raise in FY2026 earnings guidance positioned ENSG ahead of consensus, prompting a Buy rating from several analysts and a modest increase in the consensus price target.

- Simply Wall St reported that the stock was up roughly 7% earlier in the week after the guidance revision, indicating that the market is pricing in the higher earnings trajectory.

- Analysts generally view the revenue miss as a temporary timing issue, noting that the company’s 18.4% YoY revenue growth and strong occupancy trends suggest the top line will rebound in subsequent quarters.

Overall, Ensign’s ability to deliver robust earnings growth, improve Medicare and managed‑care mix, and raise its full‑year outlook outweighs the Q1 revenue miss, supporting a cautiously optimistic outlook for the remainder of 2026.